Table 3. 20-HETE, DiHETE and EETs levels according to different genotype combinations in patients and controls.

	Stroke patients combination of rs17110453CC, rs751141GG, and rs9333025GG (n = 36)	Stroke patients other genotype combination (n = 187)	Controls combination of rs17110453CC, rs751141GG, and rs9333025GG (n = 16)	Controls other genotype combination (n = 110)
20-HETE (pmol/L)	1756 ± 172†‡	1452 ± 161	1521 ± 126	1396 ± 111
DiHETEs (nmol/l)	84.23 ± 5.21†‡	71.72 ± 4.56	72.62 ± 4.73	68.98 ± 4.54
EETs (nmol/l)	60.65 ± 4.27†‡	73.72 ± 5.13	70.87 ± 4.56	75.55 ± 5.01

HETE, hydroxyeicosatetraenoic acid; DiHETEs, dihydroxyeicosatrienoic acids; EET, epoxyeicosatrienoic acids.

^†P < 0.001, compared with controls with the genotype combination of rs17110453CC, rs751141GG, and rs9333025GG.

^‡P < 0.001, compared with stroke patients with other genotype combination.